News & events
Q-linea’s rights issue is registered – conversion of BTU into shares and warrants
Q-linea shares progress on roll-out in the Middle East
Q-linea AB (publ) (OMX: QLINEA) today shared updates on the progress of the introduction of ASTar® System in the...
Read more >
Q-linea resolves to carry out a directed issue of units to guarantors in connection with the completed preferential rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces that the Company's board, with the support of...
Read more >
Ghent University publishes ASTar study results
Q-linea AB (publ) (OMX:QLINEA) today announces that results from a Belgian study have been published in the European Journal...
Read more >
Vikas Gupta, PharmD, FIDSA joins Q-linea as Senior Director of Clinical Affairs
Q-linea AB (publ) (OMX: QLINEA) today announces that Dr. Vikas Gupta, a Fellow of the Infectious Diseases Society of...
Read more >
Load more